![YB2/0 [YB2/3HL.P2.G11.16Ag.20]](/static/images/cells-no_picture.jpg)
-
平臺(tái)編號(hào)：bio-68867
-
國(guó)際編號(hào)：CRL-1662?
-
細(xì)胞信息： YB2/0 [YB2/3HL.P2.G11.16Ag.20]
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
YB2/0 [YB2/3HL.P2.G11.16Ag.20]
細(xì)胞形態(tài)：淋巴樣
運(yùn)輸方式：凍存運(yùn)輸
生長(zhǎng)狀態(tài)：懸浮生長(zhǎng)
是否是腫瘤細(xì)胞：0
物種來(lái)源：大鼠
ATCC Number：CRL-1662?
數(shù)量：大量
規(guī)格：0.5mg Designations: YB2/0 [YB2/3HL.P2.G11.16Ag.20]
Depositors: ?C Milstein
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Rattus norvegicus deposited as Rattus sp.
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphoblast;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:This line was produced by fusing Y3/Ag1.2.3 (ATCC CRL-1631 ) cells with spleen cells from an AO strain rat.
The cells do not secrete either heavy or light immunoglobulin chains.
The cells are resistant to 8-azaguanine, are HAT sensitive and can be used as a fusion partner for rat B cells to make rat - rat hybridomas.
Tested and found negative for ectromelia virus (mousepox).
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures are maintained by addition or replacement of fresh medium. Start new cultures at 1 X 10 exp5 viable cells/ml and maintain at or below 1 X 10 exp6 cells/ml.
References: 1094: Kilmartin JV, et al. Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line. J. Cell Biol. 93: 576-582, 1982. PubMed: 6811596
22292: . . Methods Enzymol. 73B: 1-46, 1981.
運(yùn)輸方式：凍存運(yùn)輸
生長(zhǎng)狀態(tài)：懸浮生長(zhǎng)
是否是腫瘤細(xì)胞：0
物種來(lái)源：大鼠
ATCC Number：CRL-1662?
數(shù)量：大量
規(guī)格：0.5mg Designations: YB2/0 [YB2/3HL.P2.G11.16Ag.20]
Depositors: ?C Milstein
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Rattus norvegicus deposited as Rattus sp.
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphoblast;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:This line was produced by fusing Y3/Ag1.2.3 (ATCC CRL-1631 ) cells with spleen cells from an AO strain rat.
The cells do not secrete either heavy or light immunoglobulin chains.
The cells are resistant to 8-azaguanine, are HAT sensitive and can be used as a fusion partner for rat B cells to make rat - rat hybridomas.
Tested and found negative for ectromelia virus (mousepox).
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures are maintained by addition or replacement of fresh medium. Start new cultures at 1 X 10 exp5 viable cells/ml and maintain at or below 1 X 10 exp6 cells/ml.
References: 1094: Kilmartin JV, et al. Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line. J. Cell Biol. 93: 576-582, 1982. PubMed: 6811596
22292: . . Methods Enzymol. 73B: 1-46, 1981.
